572 related articles for article (PubMed ID: 11529248)
1. VEGF gene transfer for diabetic neuropathy.
Isner JM; Ropper A; Hirst K
Hum Gene Ther; 2001 Aug; 12(12):1593-4. PubMed ID: 11529248
[TBL] [Abstract][Full Text] [Related]
2. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication.
Rajagopalan S; Mohler ER; Lederman RJ; Mendelsohn FO; Saucedo JF; Goldman CK; Blebea J; Macko J; Kessler PD; Rasmussen HS; Annex BH
Circulation; 2003 Oct; 108(16):1933-8. PubMed ID: 14504183
[TBL] [Abstract][Full Text] [Related]
3. Regional Angiogenesis with Vascular Endothelial Growth Factor (VEGF) in peripheral arterial disease: Design of the RAVE trial.
Rajagopalan S; Mohler E; Lederman RJ; Saucedo J; Mendelsohn FO; Olin J; Blebea J; Goldman C; Trachtenberg JD; Pressler M; Rasmussen H; Annex BH; Hirsch AT;
Am Heart J; 2003 Jun; 145(6):1114-8. PubMed ID: 12796772
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenesis mediates cisplatin-induced peripheral neuropathy: attenuation or reversal by local vascular endothelial growth factor gene therapy without augmenting tumor growth.
Kirchmair R; Walter DH; Ii M; Rittig K; Tietz AB; Murayama T; Emanueli C; Silver M; Wecker A; Amant C; Schratzberger P; Yoon YS; Weber A; Panagiotou E; Rosen KM; Bahlmann FH; Adelman LS; Weinberg DH; Ropper AH; Isner JM; Losordo DW
Circulation; 2005 May; 111(20):2662-70. PubMed ID: 15897348
[TBL] [Abstract][Full Text] [Related]
5. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT).
Hedman M; Hartikainen J; Syvänne M; Stjernvall J; Hedman A; Kivelä A; Vanninen E; Mussalo H; Kauppila E; Simula S; Närvänen O; Rantala A; Peuhkurinen K; Nieminen MS; Laakso M; Ylä-Herttuala S
Circulation; 2003 Jun; 107(21):2677-83. PubMed ID: 12742981
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acute limb ischemia by intramuscular injection of vascular endothelial growth factor gene.
Tsurumi Y; Kearney M; Chen D; Silver M; Takeshita S; Yang J; Symes JF; Isner JM
Circulation; 1997 Nov; 96(9 Suppl):II-382-8. PubMed ID: 9386128
[TBL] [Abstract][Full Text] [Related]
7. Reversal of experimental diabetic neuropathy by VEGF gene transfer.
Schratzberger P; Walter DH; Rittig K; Bahlmann FH; Pola R; Curry C; Silver M; Krainin JG; Weinberg DH; Ropper AH; Isner JM
J Clin Invest; 2001 May; 107(9):1083-92. PubMed ID: 11342572
[TBL] [Abstract][Full Text] [Related]
8. Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy.
Schratzberger P; Schratzberger G; Silver M; Curry C; Kearney M; Magner M; Alroy J; Adelman LS; Weinberg DH; Ropper AH; Isner JM
Nat Med; 2000 Apr; 6(4):405-13. PubMed ID: 10742147
[TBL] [Abstract][Full Text] [Related]
9. VEGF 164 gene transfer by electroporation improves diabetic sensory neuropathy in mice.
Murakami T; Arai M; Sunada Y; Nakamura A
J Gene Med; 2006 Jun; 8(6):773-81. PubMed ID: 16518878
[TBL] [Abstract][Full Text] [Related]
10. Clinical protocol. A phase IIb, randomized, multicenter, double-blind study of the efficacy and safety of Trinam (EG004) in stenosis prevention at the graft-vein anastomosis site in dialysis patients.
Fuster V; Charlton P; Boyd A
Hum Gene Ther; 2001 Nov; 12(16):2025-7. PubMed ID: 11727735
[TBL] [Abstract][Full Text] [Related]
11. Sonic hedgehog induces arteriogenesis in diabetic vasa nervorum and restores function in diabetic neuropathy.
Kusano KF; Allendoerfer KL; Munger W; Pola R; Bosch-Marce M; Kirchmair R; Yoon YS; Curry C; Silver M; Kearney M; Asahara T; Losordo DW
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2102-7. PubMed ID: 15358602
[TBL] [Abstract][Full Text] [Related]
12. Gene transfer of an engineered transcription factor promoting expression of VEGF-A protects against experimental diabetic neuropathy.
Price SA; Dent C; Duran-Jimenez B; Liang Y; Zhang L; Rebar EJ; Case CC; Gregory PD; Martin TJ; Spratt SK; Tomlinson DR
Diabetes; 2006 Jun; 55(6):1847-54. PubMed ID: 16731852
[TBL] [Abstract][Full Text] [Related]
13. Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial.
Vinik AI; Bril V; Kempler P; Litchy WJ; Tesfaye S; Price KL; Bastyr EJ;
Clin Ther; 2005 Aug; 27(8):1164-80. PubMed ID: 16199243
[TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
15. A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy.
Casellini CM; Barlow PM; Rice AL; Casey M; Simmons K; Pittenger G; Bastyr EJ; Wolka AM; Vinik AI
Diabetes Care; 2007 Apr; 30(4):896-902. PubMed ID: 17392551
[TBL] [Abstract][Full Text] [Related]
16. Skin capillary permeability in the diabetic foot with critical limb ischaemia: the effects of a phVEGF165 gene product.
de Leeuw K; Kusumanto Y; Smit AJ; Oomen P; van der Hoeven JH; Mulder NH; Hospers GA
Diabet Med; 2008 Oct; 25(10):1241-4. PubMed ID: 19046206
[TBL] [Abstract][Full Text] [Related]
17. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy.
Ekberg K; Brismar T; Johansson BL; Lindström P; Juntti-Berggren L; Norrby A; Berne C; Arnqvist HJ; Bolinder J; Wahren J
Diabetes Care; 2007 Jan; 30(1):71-6. PubMed ID: 17192336
[TBL] [Abstract][Full Text] [Related]
18. Endothelial and neural regulation of skin microvascular blood flow in patients with diabetic peripheral neuropathy: effect of treatment with the isoform-specific protein kinase C beta inhibitor, ruboxistaurin.
Brooks B; Delaney-Robinson C; Molyneaux L; Yue DK
J Diabetes Complications; 2008; 22(2):88-95. PubMed ID: 18280438
[TBL] [Abstract][Full Text] [Related]
19. Neurovascular factors in wound healing in the foot skin of type 2 diabetic subjects.
Krishnan ST; Quattrini C; Jeziorska M; Malik RA; Rayman G
Diabetes Care; 2007 Dec; 30(12):3058-62. PubMed ID: 17898089
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, placebo-controlled, multicenter, pilot study of the safety and feasibility of catheter-based intramyocardial injection of AdVEGF121 in patients with refractory advanced coronary artery disease.
Fuchs S; Dib N; Cohen BM; Okubagzi P; Diethrich EB; Campbell A; Macko J; Kessler PD; Rasmussen HS; Epstein SE; Kornowski R
Catheter Cardiovasc Interv; 2006 Sep; 68(3):372-8. PubMed ID: 16892433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
